Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Cervical Cancer

  Free Subscription


1 Acta Biochim Biophys Sin (Shanghai)
1 Am J Cancer Res
1 Ann Pharmacother
1 Ann Transl Med
1 Apoptosis
1 BMC Cancer
2 Cancer Causes Control
1 Caspian J Intern Med
1 Clin Lab
1 Curr Cancer Drug Targets
2 Cytopathology
1 EBioMedicine
1 Enferm Infecc Microbiol Clin (Engl Ed)
1 Eur J Radiol
1 Evid Based Complement Alternat Med
1 Exp Ther Med
1 Expert Rev Vaccines
3 Front Oncol
1 Front Public Health
1 Georgian Med News
1 Ginekol Pol
1 Gynecol Oncol
1 Health Promot Int
1 Int Immunopharmacol
2 Int J Environ Res Public Health
2 Int J Gynaecol Obstet
2 Int J Gynecol Cancer
3 Int J Gynecol Pathol
1 Int J Radiat Oncol Biol Phys
1 Int J Womens Health
1 J Immunol Res
2 J Med Screen
1 J Med Virol
4 J Obstet Gynaecol
1 J Oncol
1 J Rheumatol
1 JCO Glob Oncol
2 Lancet Glob Health
1 Med Phys
1 Palliat Support Care
2 Pathology
1 PLoS One
1 Radiat Oncol
1 Radiol Oncol
1 Sci Rep
1 Sex Transm Infect
1 Technol Cancer Res Treat
2 Vaccine

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Acta Biochim Biophys Sin (Shanghai)

  1. ZHANG Z, Hu Q, Ye S, Xiang L, et al
    Inhibition of the PIN1-NRF2/GPX4 axis imparts sensitivity to cisplatin in cervical cancer cells.
    Acta Biochim Biophys Sin (Shanghai). 2022 Aug 25. doi: 10.3724/abbs.2022109.
    PubMed         Abstract available

    Am J Cancer Res

  2. HAN GH, Yun H, Kim J, Chung JY, et al
    Overexpression of glucocorticoid receptor promotes the poor progression and induces cisplatin resistance through p38 MAP kinase in cervical cancer patients.
    Am J Cancer Res. 2022;12:3437-3454.
    PubMed         Abstract available

    Ann Pharmacother

  3. HEITZ N, Greer SC, Halford Z
    A Review of Tisotumab Vedotin-tftv in Recurrent or Metastatic Cervical Cancer.
    Ann Pharmacother. 2022 Aug 12:10600280221118370. doi: 10.1177/10600280221118370.
    PubMed         Abstract available

    Ann Transl Med

  4. LI T, Lai Y, Yuan J
    The diagnostic accuracy of TCT + HPV-DNA for cervical cancer: systematic review and meta-analysis.
    Ann Transl Med. 2022;10:761.
    PubMed         Abstract available


  5. LIU Y, Liu H, Sheng B, Pan S, et al
    The functions of lncRNAs in the HPV-negative cervical cancer compared with HPV-positive cervical cancer.
    Apoptosis. 2022 Aug 18. pii: 10.1007/s10495-022-01761.
    PubMed         Abstract available

    BMC Cancer

  6. GLASMEYER L, Mcharo RD, Torres L, Lennemann T, et al
    Long-term follow-up on HIV infected and non-infected women with cervical cancer from Tanzania: staging, access to cancer-directed therapies and associated survival in a real-life remote setting.
    BMC Cancer. 2022;22:892.
    PubMed         Abstract available

    Cancer Causes Control

  7. ELMORE CE, Mitchell EM, Debnam K, Keim-Malpass J, et al
    Predictors of cervical cancer screening for refugee women attending an international family medicine clinic in the United States.
    Cancer Causes Control. 2022 Aug 17. pii: 10.1007/s10552-022-01612.
    PubMed         Abstract available

  8. POPALIS ML, Ramirez SI, Leach KM, Granzow ME, et al
    Improving cervical cancer screening rates: a scoping review of resources and interventions.
    Cancer Causes Control. 2022 Aug 18. pii: 10.1007/s10552-022-01618.
    PubMed         Abstract available

    Caspian J Intern Med

  9. HAJIESMAEIL M, Mirzaei Dahka S, Khorrami R, Rastgoo S, et al
    Intake of food groups and cervical cancer in women at risk for cervical cancer: A nested case-control study.
    Caspian J Intern Med. 2022;13:599-606.
    PubMed         Abstract available

    Clin Lab

  10. HOSSEINI E, Yaghoubian SS, Hashemi-Soteh SMB
    The Frequency and Typing of HPV Virus Among Suspected Women Referred to HPV Genotyping Test in Mazandaran, Northern Iran.
    Clin Lab. 2022;68.
    PubMed         Abstract available

    Curr Cancer Drug Targets

  11. LIU P, Pei JJ, Li L, Li JW, et al
    Sildenafil inhibits the growth and epithelial-to-mesenchymal transition of cervical cancer via the TGF-beta1/Smad2/3 pathway.
    Curr Cancer Drug Targets. 2022 Aug 16. pii: CCDT-EPUB-125488.
    PubMed         Abstract available


  12. COSTA AF, Pogere A, Pasinato APBF, Onofre ASC, et al
    DNA image cytometry parameters to identify high-grade cervical lesions.
    Cytopathology. 2022;33:563-571.
    PubMed         Abstract available

  13. OKODO M, Okayama K, Misawa Y, Tsukakoshi N, et al
    Effects of the menstrual cycle on cytological false-negatives in women with persistent cervical intraepithelial neoplasia.
    Cytopathology. 2022;33:591-599.
    PubMed         Abstract available


  14. SHIRAZ A, Egawa N, Pelt DM, Crawford R, et al
    Cervical cell lift: A novel triage method for the spatial mapping and grading of precancerous cervical lesions.
    EBioMedicine. 2022;82:104157.
    PubMed         Abstract available

    Enferm Infecc Microbiol Clin (Engl Ed)

  15. HERNANDEZ-AGUADO JJ, de La Fuente-Valero J, Ramirez Mena M, Ortega-Medina L, et al
    Comparative pilot study about HPV test with partial genotyping in primary screening versus other strategies for cervical cancer population screening, CRYGEN 16/18 study.
    Enferm Infecc Microbiol Clin (Engl Ed). 2022 Aug 10. pii: S2529-993X(22)00169.
    PubMed         Abstract available

    Eur J Radiol

  16. BAI Z, Shi J, Wang J, Zhong J, et al
    ADC and kinetic parameter of primary tumor: Surrogate imaging markers for fertility-sparing vaginal radical trachelectomy in patients with stage IB cervical cancer.
    Eur J Radiol. 2022;155:110467.
    PubMed         Abstract available

    Evid Based Complement Alternat Med

  17. LU Y, Xu L, Lin X, Qi X, et al
    Analysis of the Effect of Fast Recovery Surgery Concept on Perioperative Nursing Care of Patients with Radical Resection of Cervical Cancer and Its Influence on Psychological Status.
    Evid Based Complement Alternat Med. 2022;2022:2023159.
    PubMed         Abstract available

    Exp Ther Med

  18. YANG B, Cai Y, Zhu P, Jiang Z, et al
    Transmembrane protein 121 as a novel inhibitor of cervical cancer metastasis.
    Exp Ther Med. 2022;24:572.
    PubMed         Abstract available

    Expert Rev Vaccines

  19. MEHTA A, Markman B, Rodriguez-Cintron W
    Don't jump down my throat: gender gap in HPV vaccinations risk long term cancer threats.
    Expert Rev Vaccines. 2022;21:1045-1053.
    PubMed         Abstract available

    Front Oncol

  20. LI Y, Wu W, Sun Y, Yu D, et al
    The clinical evaluation of atlas-based auto-segmentation for automatic contouring during cervical cancer radiotherapy.
    Front Oncol. 2022;12:945053.
    PubMed         Abstract available

  21. ZHANG J, Shen Q, Xia L, Zhu X, et al
    DYNLT3 overexpression induces apoptosis and inhibits cell growth and migration via inhibition of the Wnt pathway and EMT in cervical cancer.
    Front Oncol. 2022;12:889238.
    PubMed         Abstract available

  22. ZHANG Z, Xiang K, Tan L, Du X, et al
    Identification of critical genes associated with radiotherapy resistance in cervical cancer by bioinformatics.
    Front Oncol. 2022;12:967386.
    PubMed         Abstract available

    Front Public Health

  23. ZHU P, Tatar O, Haward B, Griffin-Mathieu G, et al
    Assessing Canadian women's preferences for cervical cancer screening: A brief report.
    Front Public Health. 2022;10:962039.
    PubMed         Abstract available

    Georgian Med News

  24. GARGIN V, Volokhova H, Koshelnyk O, Gulbs O, et al
    Georgian Med News. 2022;:40-44.
    PubMed         Abstract available

    Ginekol Pol

  25. WAN X, Hu T, Wu H, Cheng X, et al
    Predictive values of PDL1 expression for survival outcomes in patients with cervical cancer: a systematic review and meta-analysis.
    Ginekol Pol. 2022 Aug 19. pii: VM/OJS/J/89728. doi: 10.5603/GP.a2022.0071.
    PubMed         Abstract available

    Gynecol Oncol

  26. KIM Y, Kim SI, Kim H, Lee M, et al
    Open versus minimally invasive radical hysterectomy for early cervical cancer: A two-center retrospective cohort study with pathologic review of usual-type adenocarcinoma and adenosquamous carcinoma.
    Gynecol Oncol. 2022 Aug 12. pii: S0090-8258(22)00541.
    PubMed         Abstract available

    Health Promot Int

  27. KHUMALO PG, Carey M, Mackenzie L, Sanson-Fisher R, et al
    Cervical cancer screening-related knowledge among community health workers in Eswatini: a cross-sectional survey.
    Health Promot Int. 2022;37.
    PubMed         Abstract available

    Int Immunopharmacol

  28. QU N, Wang R, Meng Y, Liu N, et al
    Methionine enkephalin inhibited cervical carcinoma via apoptosis promotion and reduction of myeloid derived suppressor cell infiltrated in tumor.
    Int Immunopharmacol. 2022;110:108933.
    PubMed         Abstract available

    Int J Environ Res Public Health

  29. WENCEL-WAWRZENCZYK A, Lewitowicz P, Lewandowska A, Saluga A, et al
    Sexual Behavior and the Awareness Level of Common Risk Factors for the Development of Cervical, Anogenital and Oropharyngeal Cancer among Women Subjected to HR HPV DNA-Testing.
    Int J Environ Res Public Health. 2022;19.
    PubMed         Abstract available

  30. ARMIN JS, Williamson HJ, Begay A, Etcitty J, et al
    Adapting a Cancer Screening Education Program for Native American Women with Disabilities.
    Int J Environ Res Public Health. 2022;19.
    PubMed         Abstract available

    Int J Gynaecol Obstet

  31. RAMIREZ M, de la Fuente J, Andia D, Hernandez JJ, et al
    "HPV vaccination coverage in women between 15-55 years in Spain. Temporal trend during the period 2007-2020".
    Int J Gynaecol Obstet. 2021 Dec 14. doi: 10.1002/ijgo.14067.

  32. DAU H, Trawin J, Nakisige C, Payne BA, et al
    The social and economic impacts of cervical cancer on women and children in low- and middle-income countries: a systematic review.
    Int J Gynaecol Obstet. 2022 Aug 13. doi: 10.1002/ijgo.14395.
    PubMed         Abstract available

    Int J Gynecol Cancer

  33. NOBREGA L, Zanon JR, Andrade CEEMDC, Schmidt RL, et al
    Prognostic role of hydronephrosis in the treatment of patients with locally advanced cervical cancer: a retrospective cohort.
    Int J Gynecol Cancer. 2022 Aug 16. pii: ijgc-2022-003679.
    PubMed         Abstract available

  34. FRANCOEUR AA, Liao CI, Casear MA, Chan A, et al
    The increasing incidence of stage IV cervical cancer in the USA: what factors are related?
    Int J Gynecol Cancer. 2022 Aug 18. pii: ijgc-2022-003728.
    PubMed         Abstract available

    Int J Gynecol Pathol

  35. SAH S, Borkar PV, Wight C, Kelly P, et al
    Low-grade Neuroendocrine Tumor of the Cervix: Report of 3 Cases of a Rare Neoplasm With Review of the Literature.
    Int J Gynecol Pathol. 2022;41:437-446.
    PubMed         Abstract available

  36. BULUTAY P, Haberal N, Ozen O, Erdem O, et al
    Reproducibility of Morphologic Parameters of the International Endocervical Adenocarcinoma Criteria and Classification System and Correlation With Clinicopathologic Parameters: A Multi-Institutional Study.
    Int J Gynecol Pathol. 2022;41:447-458.
    PubMed         Abstract available

  37. KATAFUCHI T, Kawakami F, Iwagoi Y, Saito F, et al
    "Neuroendocrine Tumor Grade 3 (NET G3)" of the Uterine Cervix: A Report of 2 Cases.
    Int J Gynecol Pathol. 2022;41:470-475.
    PubMed         Abstract available

    Int J Radiat Oncol Biol Phys

  38. MARAR M, Simiele E, Niedermayr T, Kidd EA, et al
    Applying 3D-Printed Templates in High-Dose-Rate Brachytherapy for Cervix Cancer: Simplified Needle Insertion for Optimized Dosimetry.
    Int J Radiat Oncol Biol Phys. 2022;114:111-119.
    PubMed         Abstract available

    Int J STD AIDS

  39. MCCLYMONT E, Albert AY, Wang C, Dos Santos SJ, et al
    Vaginal microbiota associated with oncogenic HPV in a cohort of HPV-vaccinated women living with HIV.
    Int J STD AIDS. 2022 Jul 1:9564624221109686. doi: 10.1177/09564624221109686.
    PubMed         Abstract available

    Int J Womens Health

  40. CUI H, Zhang B, Ruan M, Fang C, et al
    Overexpression of miR-3653 is Associated with HPV Infection and Serves as a Biomarker in Patients with Cervical Cancer.
    Int J Womens Health. 2022;14:1037-1045.
    PubMed         Abstract available

    J Immunol Res

  41. ZHOU G, Zhou F, Gu Y, Zhang M, et al
    Vaginal Microbial Environment Skews Macrophage Polarization and Contributes to Cervical Cancer Development.
    J Immunol Res. 2022;2022:3525735.
    PubMed         Abstract available

    J Med Screen

  42. DRYSDALE H, Marlow LA, Lim A, Sasieni P, et al
    Self-sampling for cervical screening offered at the point of invitation: A cross-sectional study of preferences in England.
    J Med Screen. 2022;29:194-202.
    PubMed         Abstract available

  43. SULTANA F, Gertig DM, English DR, Simpson JA, et al
    HPV self-sampling and follow-up over two rounds of cervical screening in Australia - the iPap trial.
    J Med Screen. 2022;29:185-193.
    PubMed         Abstract available

    J Med Virol

  44. ALTAY-KOCAK A, Kazanci F, Dogu-Tok C, Onan A, et al
    The prevalence and distribution of human papillomavirus in 4267 Turkish women with or without cervical lesions: A hospital-based study.
    J Med Virol. 2022;94:5026-5032.
    PubMed         Abstract available

    J Obstet Gynaecol

  45. ZHANG W, Gao Y, Zhang W, Lin Z, et al
    Survival outcomes and prognostic factors of papillary serous adenocarcinoma and papillary squamous cell carcinoma of the uterine cervix.
    J Obstet Gynaecol. 2022;42:1233-1238.
    PubMed         Abstract available

  46. MOOSSAVI M, Shojaee M, Mousavi M, Alaei M, et al
    Evaluating the HLA-G (rs1063320) genetic variant and risk of human papillomavirus infection: a meta-analysis of 953 cases and 877 controls.
    J Obstet Gynaecol. 2022;42:1352-1357.
    PubMed         Abstract available

  47. GOLD RS, Amir H, Baruch Y, Gordon D, et al
    The Manchester operation - is it time for it to return to our surgical armamentarium in the twenty-first century?
    J Obstet Gynaecol. 2022;42:1419-1423.
    PubMed         Abstract available

  48. SAYYAH-MELLI M, Shokohi B, Yagoobi S, Adili A, et al
    Immature teratoma of the uterine cervix.
    J Obstet Gynaecol. 2022;42:1600-1601.

    J Oncol

  49. GUAN C, Wang B, Dong Q
    The IncRNA SCIRT Promotes the Proliferative, Migratory, and Invasive Properties of Cervical Cancer Cells by Upregulating MMP-2/-9.
    J Oncol. 2022;2022:3448224.
    PubMed         Abstract available

    J Rheumatol

  50. CHUNG SH, Oshima K, Singleton M, Thomason J, et al
    Determinants of Cervical Cancer Screening Patterns Among Women with Systemic Lupus Erythematosus.
    J Rheumatol. 2022 Aug 15. pii: jrheum.220105. doi: 10.3899/jrheum.220105.
    PubMed         Abstract available

    JCO Glob Oncol

  51. PARASCANDOLA M, Neta G, Salloum RG, Shelley D, et al
    Role of Local Evidence in Transferring Evidence-Based Interventions to Low- and Middle-Income Country Settings: Application to Global Cancer Prevention and Control.
    JCO Glob Oncol. 2022;8:e2200054.
    PubMed         Abstract available

    Lancet Glob Health

  52. VALLELY AJB, Saville M, Badman SG, Gabuzzi J, et al
    Point-of-care HPV DNA testing of self-collected specimens and same-day thermal ablation for the early detection and treatment of cervical pre-cancer in women in Papua New Guinea: a prospective, single-arm intervention trial (HPV-STAT).
    Lancet Glob Health. 2022;10:e1336-e1346.
    PubMed         Abstract available

  53. KIARIE H, Temmerman M, Nyamai M, Liku N, et al
    The COVID-19 pandemic and disruptions to essential health services in Kenya: a retrospective time-series analysis.
    Lancet Glob Health. 2022;10:e1257-e1267.
    PubMed         Abstract available

    Med Phys

  54. VILASBOAS-RIBEIRO I, Nouwens SAN, Curto S, Jager B, et al
    POD-Kalman filtering for improving noninvasive 3D temperature monitoring in MR-guided hyperthermia.
    Med Phys. 2022;49:4955-4970.
    PubMed         Abstract available

    Palliat Support Care

  55. SHINAN-ALTMAN S, Levkovich I, Hamama-Raz Y
    Cervical cancer survivors: The experiences of the journey.
    Palliat Support Care. 2022 Aug 17:1-8. doi: 10.1017/S1478951522000785.
    PubMed         Abstract available


  56. SHI H, Shao Y, Zhang H, Ye L, et al
    Independent validation of distinct clinicopathological features and prognosis among usual-type, mucinous-type and gastric-type endocervical adenocarcinoma categorised by new WHO classification (2020).
    Pathology. 2022;54:555-562.
    PubMed         Abstract available

  57. STOLNICU S, Hoang L, Almadani N, De Brot L, et al
    Clinical correlation of lymphovascular invasion and Silva pattern of invasion in early-stage endocervical adenocarcinoma: proposed binary Silva classification system.
    Pathology. 2022;54:548-554.
    PubMed         Abstract available

    PLoS One

  58. ROMLI R, Abd Rahman R, Chew KT, Mohd Hashim S, et al
    Empirical investigation of e-health intervention in cervical cancer screening: A systematic literature review.
    PLoS One. 2022;17:e0273375.
    PubMed         Abstract available

    Radiat Oncol

  59. LIU J, Tang G, Zhou Q, Kuang W, et al
    Outcomes and prognostic factors in patients with locally advanced cervical cancer treated with concurrent chemoradiotherapy.
    Radiat Oncol. 2022;17:142.
    PubMed         Abstract available

    Radiol Oncol

  60. MLINARIC M, Krizmaric M, Takac I, Repse Fokter A, et al
    Identification of women with high grade histopathology results after conisation by artificial neural networks.
    Radiol Oncol. 2022;56:355-364.
    PubMed         Abstract available

    Sci Rep

  61. LI J, Liu G, Luo J, Yan S, et al
    Cervical cancer prognosis and related risk factors for patients with cervical cancer: a long-term retrospective cohort study.
    Sci Rep. 2022;12:13994.
    PubMed         Abstract available

    Sex Transm Infect

  62. DEMA E, Sonnenberg P, Gibbs J, Conolly A, et al
    How did the COVID-19 pandemic affect access to condoms, chlamydia and HIV testing, and cervical cancer screening at a population level in Britain? (Natsal-COVID).
    Sex Transm Infect. 2022 Aug 18. pii: sextrans-2022-055516.
    PubMed         Abstract available

    Technol Cancer Res Treat

  63. YI J, Lei X, Zhang L, Zheng Q, et al
    The Influence of Different Ultrasonic Machines on Radiomics Models in Prediction Lymph Node Metastasis for Patients with Cervical Cancer.
    Technol Cancer Res Treat. 2022;21:15330338221118412.
    PubMed         Abstract available


  64. CASTILLO-CANO B, Martin-Perez M, Llorente-Garcia A, Montero-Corominas D, et al
    Assessment of thyroiditis risk associated with HPV vaccination among girls aged 9-18 years: A time-varying cohort study.
    Vaccine. 2022 Jul 2. pii: S0264-410X(22)00829.
    PubMed         Abstract available

  65. IMANISHI Y, Kinoshita T, Sakamoto M, Ichimiya M, et al
    Importance of human papillomavirus vaccination leaflets focusing on the safety profile targeted pediatricians in Japan.
    Vaccine. 2022 Jul 13. pii: S0264-410X(22)00861.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Cervical Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.